SR

Sunita Rana

Active Director Director DIN 08118190
DIN 08118190 First appointment Apr 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2018
Shareholding value •••• Premium profile

About Sunita Rana

Data last updated:

Sunita Rana is a Director at Agond Lifesciences Private Limited (since 2018). The company operates in Pharma. Agond Lifesciences Private Limited reported revenue of ₹2.59 Cr (FY 2025).

DIN 08118190
Primary Designation Director
Industry Pharma
First Appointment 16 Apr 2018
Oldest Company Age 12 yrs
Largest company Agond Lifesciences Private Limited · ₹2.59 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Agond Lifesciences Private Limited U74999HR2013PTC050897
Director16 Apr 20182013₹2.59 Cr (FY 2025)Active

Board colleagues of Sunita Rana

NameDINCompanyDesignation
Ravinder Rana06652047Agond Lifesciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Agond Lifesciences Private Limited
Premium access

Shareholding and investment profile for Sunita Rana

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunita Rana

Sunita Rana currently holds 1 directorship: Agond Lifesciences Private Limited (Director, since 16 Apr 2018, revenue ₹2.59 Cr (FY 2025)).

Sunita Rana was first appointed on 16 Apr 2018 as Director at Agond Lifesciences Private Limited.

The current boards of Sunita Rana's companies include Ravinder Rana (Agond Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available